PharmaZell expands manufacturing site in India
European contract manufacturing organisation (CMO) PharmaZell has increased capacity at its R&D centre in Vizag, India with a new cGMP Kilo-lab for API and drug intermediate production.
“We have continued to grow our manufacturing capacity and expand our services to the pharmaceutical and biotechnology industries,” said Wolfgang Burger, of PharmaZell, adding: “We believe that our strong revenue growth and diverse customer base is positioning our company as a significant API manufacturer and service provider.”
The new laboratory is the latest in a number of expansions undertaken at the plant, which was opened in 2007 as a production site for the active pharmaceutical ingredient (API), Mesalamine.
The addition of a hi-tech R&D facility followed in 2008, along with a team of 35 chemists with expertise in process development, analytical R&D and small scale synthesis.
